Cytokinetics Incorporated (CYTK) Surged 6.46% or 0.47 To Price $7.75 On Tuesday


Cytokinetics Incorporated (CYTK) surged 6.46% or 0.47 to $7.75. It is nearly 157383 shares traded, which is 44.13% compare to the average total volume 356625. The market cap of CYTK is $424.01 million. The year to date change is 13.2%. The 52 week price range is from $5.9 to $10.0. Price of CYTK have changed 6.74% during last week. It have changed 0.00% over last month, 6.43% over last 3 months, 9.47% over last 6 months and -11.22% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYTK is 7.14. It is -7.87% below current price. The 200-day Moving Averages for CYTK is 7.83. It is 1.03% above current price. The 52-week High is 10.0. It is 29.03% from the current price. The 52-week Low is 5.9. It is -23.87% from current price.

There are some statistics of CYTK. It is has market cap $424.01 million. The share outstanding is 54.71 million. The average volume is 356625. The revenue is -18000. The percent of top 15 Institution holding is 106.70%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYTK is -121.76%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYTK is -43.49%.


Tags:

Share this post